Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Community pharmacy

Serious shortage protocols to be introduced into NHS terms of service

Changes to the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 that established the protocols were first introduced in February 2019 as part of no-deal Brexit planning.

Legal amendments that introduce serious shortage protocols (SSPs) into the terms of service for NHS community pharmacies are due to come into force from 1 July 2019, subject to approval from Matt Hancock, health and social care secretary.

The amendments to the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, which provide guidelines for pharmacies to follow, were laid before Parliament on 7 June 2019.

The guidelines say that, where a SSP is in place for a particular product, a retail pharmacy business or a dispensing appliance contractor must consider supplying it in accordance with the SSP rather than fulfilling an NHS prescription.

This could result in the supply of a different product or a different quantity of the ordered product.

However, a spokesperson for the Pharmaceutical Services Negotiating Committee (PSNC) said requirements of SSPs will vary, often according to the type of SSP, and supply may not be appropriate.

The SSP legislation was first introduced in February 2019 as part of planning for a no-deal Brexit, to enable the government to introduce alternative arrangements for supply where a medicine or appliance is ordered on prescription but there is — or may in the future be — a serious shortage of that medicine or appliance.

The PSNC, which has been working with the Department of Health and Social Care and system suppliers to agree the endorsements, fees and paperwork that will be associated with SSPs, is to provide further guidance on the implications for community pharmacy.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206657

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.